{"name":"Hrain Biotechnology Co., Ltd.","slug":"hrain-biotechnology-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Human BCMA Targeted T Cells Injection","genericName":"Human BCMA Targeted T Cells Injection","slug":"human-bcma-targeted-t-cells-injection","indication":"Multiple myeloma","status":"phase_2"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Human CD19-CD22 Targeted T Cells Injection","genericName":"Human CD19-CD22 Targeted T Cells Injection","slug":"human-cd19-cd22-targeted-t-cells-injection","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"Human BCMA Targeted T Cells Injection","genericName":"Human BCMA Targeted T Cells Injection","slug":"human-bcma-targeted-t-cells-injection","phase":"phase_2","mechanism":"BCMA-targeted T cells","indications":["Multiple myeloma"],"catalyst":""},{"name":"Human CD19-CD22 Targeted T Cells Injection","genericName":"Human CD19-CD22 Targeted T Cells Injection","slug":"human-cd19-cd22-targeted-t-cells-injection","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxQSDBXZ243SnRELU9tTG5VZTBBaUFIQkVwVmJEYW42OGc5emVxOWVhSGlZcng5U1RDZE5IWUM5YUdYRE1VSDBpVFZxTW5iNUF0X29DSUlDa3RBaHpKRmhwODNuU1hlRmEyQzNDLU9VUlVYN29vb3dTZFl1T21FU2FWNXpGZklzS2hZQXNoV21KczXSAZYBQVVfeXFMTmdVSG5xdU5Qa2JKdFpoQWYyaHhkUkxfM1FUdmljWjc5Z2VZYkxxRzhsa0VmZWZXc2h1UWY4MFFibXlwbXplT0VBS2dITk5ya1oxVlRwN3JJUF9fOFkwQlZ5eHB1NmNwRWZQV0NvMVlmSDZka3laZlZTMjNaN1FXdWxiU0hUSC1XckpWb09qRGNVSDI3UXdR?oc=5","date":"2026-01-17","type":"pipeline","source":"BioInformant","summary":"CAR-T Cell Companies Proliferate: List of CAR-T Companies Worldwide - BioInformant","headline":"CAR-T Cell Companies Proliferate: List of CAR-T Companies Worldwide","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxPQ0IyRmpWZzhoSnhlMVFEdVdtRzM2TjRtN0FfSXp5YjBSMHJVcGZwNlJxR09OODhWQWhIM3NRcV9pdEczQUhiaEs1aXpXYVlRWFlWb1k5QVVfd0t5bmQxRmVGblpDZVM4SmRtN2taaExmRU9KN3BmLU95bVRRM1V4aWtYaEZQVGpZNzRsOEVrSTdVc2FiVTFDcDJhb19DczA5M2IzM0FR?oc=5","date":"2025-12-09","type":"pipeline","source":"BioWorld News","summary":"73 Chinese biotech, med-tech companies file for HK IPOs in 2025 - BioWorld News","headline":"73 Chinese biotech, med-tech companies file for HK IPOs in 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxOSkJVaXVScmZMeUthSF9SeUw3T0Y4MHZsWTd2dmhXYVpWZmlVdkZYdzhDYlAySGlpX0s4dzUxc0FyckhCM0liZVB0NHVJU0hWZmx5ckdQRVdId0JIWDd6WmNOTndBRW5DcVRReTVuc2o0MlY4UXlvcE50dnhWY3RMV2ZfUnc5RlA0R0NTNEcyNldNSGtMZGFEd0FRQmZyQlE0OERj?oc=5","date":"2025-07-22","type":"pipeline","source":"BioWorld News","summary":"34 mainland China biotechs file for Hong Kong IPO in H1 2025 - BioWorld News","headline":"34 mainland China biotechs file for Hong Kong IPO in H1 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_AFBVV95cUxNOXcyek5vakItWXNwTWFOdFM3OEhGZmJieFYxLWl4dDRmNnlaNGN4cXZxM2VyRjMzUnBKa1dobmdmbnZIekUxR2F5eFpiQmRicGcwTlMyUVN3Zkk4aHBFYWM0ZnZnNUg0XzZTNktyeFQ1SUw3cmx0VldjdjhGeUwzNk5FNlVFekUxb0cxdUNrUVBaS3FLc1Ixa0lIZmRqRG83VlpPdWlBVk9fN1NhZzBFMlgzWkQxN01hMkhfM094d3hWSG9nOW1BMFlJQUk2TlJjbjZiN1U2NXhEU19HdXRveDNNdGp0S08yRlUzVDZNQ1VQUHpONmNNazhtcjI?oc=5","date":"2025-03-24","type":"pipeline","source":"prnewswire.com","summary":"CARVYKTI Continued Performance Reflects Growing Confidence in CAR-T Therapies for Multiple Myeloma | DelveInsight - prnewswire.com","headline":"CARVYKTI Continued Performance Reflects Growing Confidence in CAR-T Therapies for Multiple Myeloma | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwJBVV95cUxQV1JBcWNmYk85cFJyVU9PYzE1c0x3b2RjcW9fN1JUQ1FNc1BRUjNMRkltMTl3cHZCdnpoOHFvQlFCY3BrQ0ZWa1lxQnNCb055NlZyVlcwelZGd1hxRmhCVnBybXdSS1B3eFJZT1JUV0JfWGFEM2Vvc3ZJNzdRdUlPcmR4YkJjSEEyWGhIYm0xZkk0cXJLTzNXeXR3anY5cjA4eEQwbzNVWjUtSWxDdm55Ti0zWFh3TW8zUnlRcmpVTFhQc0NCMmJydTdVUzBYbXdGbGR5R2xPeWNLX3VuV0t6bWduNW1GYnhSYl8zbmFfa2lteDBGTzNtQUlKNHlOczZjYXFISHdpc3dtUm9IY0FCNmQwZ2hPeEhYdTAwaFFwTXlGd2Z4NHdpbUxiZXU1dGM5UjBrVjQ2UTc5QlJkM0NyUVlQWnBQTkU?oc=5","date":"2025-03-05","type":"trial","source":"GlobeNewswire","summary":"CAR T-cell Therapy Clinical Trial Pipeline Experiences - GlobeNewswire","headline":"CAR T-cell Therapy Clinical Trial Pipeline Experiences","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxQbUVTNkpicy1sSFFSTmRUSE5CR0tIRHF6aUVWYlk5aUFKaks2UDdJSlhCVEZPbjZsdS1vMG54cThoZ2M0R3ZQNmVkRjhoZVNOcTlxbFVkQTkxTkpvUktMSVRGYVItREE0MWVkZEIzb2dERkVRS1FEWmRaOW1HQ2plNWk0V3Z4bEpJYzU1QTNadUVqaFZVZEdYcnZvTmRtQUU?oc=5","date":"2022-08-11","type":"pipeline","source":"BioSpace","summary":"Cell and Gene Therapy Market Size, Growth, Trends, Forecast Report 2022-2030 - BioSpace","headline":"Cell and Gene Therapy Market Size, Growth, Trends, Forecast Report 2022-2030","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_2":1,"phase_1":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}